Found 6 results
Filters: Keyword is Immunoglobulin G  [Clear All Filters]
2023
Yamin R, Kao KS, MacDonald MR, Cantaert T, Rice CM, Ravetch JV, Bournazos S.  2023.  Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice.. Nat Microbiol. 8(8):1468-1479.
Gupta A, Kao KS, Yamin R, Oren DA, Goldgur Y, Du J, Lollar P, Sundberg EJ, Ravetch JV.  2023.  Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody.. Nat Commun. 14(1):2853.
2022
Kao KS, Gupta A, Zong G, Li C, Kerschbaumer I, Borghi S, Achkar JM, Bournazos S, Wang L-X, Ravetch JV.  2022.  Synthetic nanobodies as tools to distinguish IgG Fc glycoforms.. Proc Natl Acad Sci U S A. 119(48):e2212658119.
2017
Chang AY, Dao T, Gejman RS, Jarvis CA, Scott A, Dubrovsky L, Mathias MD, Korontsvit T, Zakhaleva V, Curcio M et al..  2017.  A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.. J Clin Invest. 127(7):2705-2718.
2016
Tzeng SY, Guarecuco R, McHugh KJ, Rose S, Rosenberg EM, Zeng Y, Langer R, Jaklenec A.  2016.  Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.. J Control Release. 233:101-13.
2012
Tian T, Dubin K, Jin Q, Qureshi A, King SL, Liu L, Jiang X, Murphy GF, Kupper TS, Fuhlbrigge RC.  2012.  Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection.. J Invest Dermatol. 132(5):1425-34.